|
Volumn 59, Issue 3, 2002, Pages 227-230
|
Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas
a a |
Author keywords
Ara C; High dose; Methotrexate; Primary CNS lymphoma; Radiotherapy
|
Indexed keywords
CYTARABINE;
DEXAMETHASONE;
IDARUBICIN;
IFOSFAMIDE;
METHOTREXATE;
RITUXIMAB;
STEROID;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DEATH;
DISEASE SEVERITY;
DRUG CHOICE;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG TOLERABILITY;
ELDERLY CARE;
EVIDENCE BASED MEDICINE;
FEBRILE NEUTROPENIA;
FEMALE;
FOLLOW UP;
HERPES ZOSTER ENCEPHALITIS;
HUMAN;
LEUKOPENIA;
LONG TERM CARE;
LUNG EMBOLISM;
MALE;
OUTCOMES RESEARCH;
PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;
RADIATION DOSE DISTRIBUTION;
RADIATION INJURY;
SENSORIMOTOR NEUROPATHY;
SIDE EFFECT;
TOXICITY TESTING;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRAIN NEOPLASMS;
CEREBROSPINAL FLUID;
COMBINED MODALITY THERAPY;
CYTARABINE;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
INJECTIONS, INTRAVENTRICULAR;
L-LACTATE DEHYDROGENASE;
LYMPHOMA, NON-HODGKIN;
MALE;
METHOTREXATE;
MIDDLE AGED;
NEOPLASM STAGING;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0036714234
PISSN: 0167594X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1019993018162 Document Type: Article |
Times cited : (24)
|
References (11)
|